Covered recipient · General Payments record
LUCINDA DOBBS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$2,030.28
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $523.61 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $184.02 | 10 |
| Amgen Inc. | $148.13 | 10 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.21 | 4 |
| PFIZER INC. | $24.93 | 1 |
| Fresenius Kabi USA, LLC | $19.12 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.06 | 1 |
| Organon LLC | $17.81 | 1 |
| UCB, Inc. | $15.63 | 1 |
| Lilly USA, LLC | $14.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.64 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030193 | CMS |
| ABBVIE INC. | $13.65 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030195 | CMS |
| ABBVIE INC. | $18.90 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030197 | CMS |
| ABBVIE INC. | $15.46 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030199 | CMS |
| ABBVIE INC. | $24.12 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030201 | CMS |
| ABBVIE INC. | $15.19 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030203 | CMS |
| ABBVIE INC. | $16.09 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030205 | CMS |
| ABBVIE INC. | $2.44 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030207 | CMS |
| ABBVIE INC. | $23.82 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030209 | CMS |
| ABBVIE INC. | $27.71 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107030211 | CMS |
| Amgen Inc. | $5.88 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240186 | CMS |
| Amgen Inc. | $12.07 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240180 | CMS |
| Amgen Inc. | $12.63 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240188 | CMS |
| Amgen Inc. | $17.48 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240196 | CMS |
| Amgen Inc. | $9.60 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240190 | CMS |
| Amgen Inc. | $24.75 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240192 | CMS |
| Amgen Inc. | $24.07 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117542836 | CMS |
| Amgen Inc. | $12.07 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240182 | CMS |
| Amgen Inc. | $18.96 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240194 | CMS |
| Amgen Inc. | $10.62 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240184 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118092514 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.51 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118092512 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.05 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118092510 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.65 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118092516 | CMS |
| Fresenius Kabi USA, LLC | $19.12 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146948531 | CMS |
| Lilly USA, LLC | $14.70 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135805824 | CMS |
| Novartis Pharmaceuticals Corporation | $19.06 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086852589 | CMS |
| Organon Llc | $17.81 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136260891 | CMS |
| PFIZER INC. | $24.93 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131719922 | CMS |
| UCB, Inc. | $15.63 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143034203 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.